Cargando…
P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428712/ http://dx.doi.org/10.1097/01.HS9.0000969012.27994.b8 |
| _version_ | 1785090534780436480 |
|---|---|
| author | Lech-Marańda, Ewa Szymańska, Agata Zaucha, Jan Borthakur, Gautam Solomon, Scott Bradley, Terrence Mouhayar, Elie Angelosanto, Noemi Nogai, Hendrik Brzozka, Krzysztof Rzymski, Tomasz Littlewood, Peter Kus, Kamil Dudziak, Renata Glasmacher, Axel Burris, Howard Abboud, Camille |
| author_facet | Lech-Marańda, Ewa Szymańska, Agata Zaucha, Jan Borthakur, Gautam Solomon, Scott Bradley, Terrence Mouhayar, Elie Angelosanto, Noemi Nogai, Hendrik Brzozka, Krzysztof Rzymski, Tomasz Littlewood, Peter Kus, Kamil Dudziak, Renata Glasmacher, Axel Burris, Howard Abboud, Camille |
| author_sort | Lech-Marańda, Ewa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428712 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104287122023-08-17 P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA Lech-Marańda, Ewa Szymańska, Agata Zaucha, Jan Borthakur, Gautam Solomon, Scott Bradley, Terrence Mouhayar, Elie Angelosanto, Noemi Nogai, Hendrik Brzozka, Krzysztof Rzymski, Tomasz Littlewood, Peter Kus, Kamil Dudziak, Renata Glasmacher, Axel Burris, Howard Abboud, Camille Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428712/ http://dx.doi.org/10.1097/01.HS9.0000969012.27994.b8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Lech-Marańda, Ewa Szymańska, Agata Zaucha, Jan Borthakur, Gautam Solomon, Scott Bradley, Terrence Mouhayar, Elie Angelosanto, Noemi Nogai, Hendrik Brzozka, Krzysztof Rzymski, Tomasz Littlewood, Peter Kus, Kamil Dudziak, Renata Glasmacher, Axel Burris, Howard Abboud, Camille P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA |
| title | P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA |
| title_full | P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA |
| title_fullStr | P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA |
| title_full_unstemmed | P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA |
| title_short | P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA |
| title_sort | p526: safety and efficacy update from cli120-001: a phase1b dose escalation study in relapse-refractory acute myeloid leukemia and high-risk myelodysplasia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428712/ http://dx.doi.org/10.1097/01.HS9.0000969012.27994.b8 |
| work_keys_str_mv | AT lechmarandaewa p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT szymanskaagata p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT zauchajan p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT borthakurgautam p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT solomonscott p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT bradleyterrence p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT mouhayarelie p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT angelosantonoemi p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT nogaihendrik p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT brzozkakrzysztof p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT rzymskitomasz p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT littlewoodpeter p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT kuskamil p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT dudziakrenata p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT glasmacheraxel p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT burrishoward p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia AT abboudcamille p526safetyandefficacyupdatefromcli120001aphase1bdoseescalationstudyinrelapserefractoryacutemyeloidleukemiaandhighriskmyelodysplasia |